5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Pulmonary Stenosis
Pulmonary stenosis is a cardiovascular condition characterized by the narrowing or constriction of the pulmonary valve, the gateway between the right ventricle of the heart and the pulmonary artery. This narrowing impedes the smooth flow of blood from the heart to the lungs, placing increased strain on the right ventricle. Commonly a congenital defect, pulmonary stenosis varies in severity, with symptoms ranging from mild to severe. Individuals with mild cases may remain asymptomatic for years, while severe cases can lead to symptoms such as chest pain, fatigue, and fainting. Timely diagnosis and intervention, often through surgical procedures or balloon valvuloplasty, are crucial for managing pulmonary stenosis and preventing complications. Regular medical monitoring is essential to ensure optimal heart function and overall well-being for individuals affected by this condition.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain